10x Genomics (TXG) News Today $14.04 +0.43 (+3.16%) (As of 12/20/2024 05:40 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period State Street Corp Has $39.53 Million Position in 10x Genomics, Inc. (NASDAQ:TXG)State Street Corp increased its holdings in 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 7.1% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,750,643 shares of the company's stock after purchasing anDecember 21 at 3:24 AM | marketbeat.comBarclays PLC Has $13.61 Million Stock Position in 10x Genomics, Inc. (NASDAQ:TXG)Barclays PLC lifted its position in shares of 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 11.7% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 602,536 shares of the company's stock after purchasing an aDecember 16, 2024 | marketbeat.comXTX Topco Ltd Purchases 31,844 Shares of 10x Genomics, Inc. (NASDAQ:TXG)XTX Topco Ltd grew its stake in 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 241.9% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 45,008 shares of the company's stock after purchasing an additional 31,8December 11, 2024 | marketbeat.com46,029 Shares in 10x Genomics, Inc. (NASDAQ:TXG) Purchased by Weiss Asset Management LPWeiss Asset Management LP bought a new stake in shares of 10x Genomics, Inc. (NASDAQ:TXG - Free Report) in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 46,029 shares of the company's stock, valued at appDecember 9, 2024 | marketbeat.comQuantinno Capital Management LP Grows Stock Position in 10x Genomics, Inc. (NASDAQ:TXG)Quantinno Capital Management LP raised its position in 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 380.5% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 235,026 shares of the company's stock afteDecember 8, 2024 | marketbeat.com10x Genomics, Inc. (NASDAQ:TXG) Shares Sold by Charles Schwab Investment Management Inc.Charles Schwab Investment Management Inc. decreased its holdings in shares of 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 32.5% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 651,582 shares of the comDecember 8, 2024 | marketbeat.comPoint72 Asset Management L.P. Makes New $27.78 Million Investment in 10x Genomics, Inc. (NASDAQ:TXG)Point72 Asset Management L.P. purchased a new stake in shares of 10x Genomics, Inc. (NASDAQ:TXG - Free Report) during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 1,230,189 shares of the company's stoDecember 6, 2024 | marketbeat.comBenjamin Edwards Inc. Purchases 57,948 Shares of 10x Genomics, Inc. (NASDAQ:TXG)Benjamin Edwards Inc. increased its position in shares of 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 18,454.8% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 58,262 shares of the company's stock afterDecember 6, 2024 | marketbeat.com10x Genomics, Inc. (NASDAQ:TXG) Given Consensus Recommendation of "Moderate Buy" by AnalystsShares of 10x Genomics, Inc. (NASDAQ:TXG - Get Free Report) have been assigned a consensus rating of "Moderate Buy" from the seventeen analysts that are currently covering the company, MarketBeat.com reports. One analyst has rated the stock with a sell recommendation, seven have assigned a hold rDecember 6, 2024 | marketbeat.comCinctive Capital Management LP Buys New Stake in 10x Genomics, Inc. (NASDAQ:TXG)Cinctive Capital Management LP purchased a new position in shares of 10x Genomics, Inc. (NASDAQ:TXG - Free Report) during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 162,585 shares of the companyDecember 3, 2024 | marketbeat.comFmr LLC Buys 357,470 Shares of 10x Genomics, Inc. (NASDAQ:TXG)Fmr LLC grew its stake in shares of 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 2.7% in the third quarter, according to the company in its most recent filing with the SEC. The firm owned 13,367,979 shares of the company's stock after acquiring an additional 357,470 shares during the quarter. FDecember 1, 2024 | marketbeat.com10x Genomics, Inc. (NASDAQ:TXG) Shares Purchased by Algert Global LLCAlgert Global LLC boosted its stake in 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 214.5% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 370,958 shares of the company's stock after acquirNovember 24, 2024 | marketbeat.comPrimecap Management Co. CA Purchases 108,600 Shares of 10x Genomics, Inc. (NASDAQ:TXG)Primecap Management Co. CA increased its position in shares of 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 58.1% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 295,400 shares of the company's stock after acquiring an adNovember 23, 2024 | marketbeat.comCIBC Asset Management Inc Sells 79,321 Shares of 10x Genomics, Inc. (NASDAQ:TXG)CIBC Asset Management Inc lowered its position in 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 83.3% in the 3rd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 15,938 shares of the company's stock after selling 79,321 shares during the period. CINovember 22, 2024 | marketbeat.com10x Genomics, Inc. (NASDAQ:TXG) Shares Sold by Brown Capital Management LLCBrown Capital Management LLC cut its holdings in shares of 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 11.6% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,195,319 shares of the company's stock after seNovember 21, 2024 | marketbeat.com10x Genomics and Beckman Coulter Life Sciences Launch New Solution to Automate Single Cell Assay WorkflowsNovember 20, 2024 | msn.com10x Genomics, Inc. (TXG): Among the Best Genomics Stocks to Buy Right NowNovember 20, 2024 | msn.comLMR Partners LLP Invests $1.59 Million in 10x Genomics, Inc. (NASDAQ:TXG)LMR Partners LLP acquired a new position in shares of 10x Genomics, Inc. (NASDAQ:TXG - Free Report) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 70,303 shares of the company's stock, valued at apprNovember 19, 2024 | marketbeat.com10x Genomics (NASDAQ:TXG) Hits New 52-Week Low - What's Next?10x Genomics (NASDAQ:TXG) Reaches New 1-Year Low - Here's WhyNovember 15, 2024 | marketbeat.comBaillie Gifford & Co. Reduces Stock Holdings in 10x Genomics, Inc. (NASDAQ:TXG)Baillie Gifford & Co. reduced its position in 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 98.5% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 40,378 shares of the company's stock after selling 2,701,775 shares duNovember 14, 2024 | marketbeat.comSumitomo Mitsui Trust Group Inc. Has $143.91 Million Holdings in 10x Genomics, Inc. (NASDAQ:TXG)Sumitomo Mitsui Trust Group Inc. lifted its position in 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 3.7% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 6,373,212 shares of the company's stock aftNovember 13, 2024 | marketbeat.com10x Genomics (NASDAQ:TXG) Stock Quotes, Forecast and News SummaryNovember 13, 2024 | benzinga.com10x Genomics, Inc. (NASDAQ:TXG) Receives Consensus Recommendation of "Moderate Buy" from BrokeragesShares of 10x Genomics, Inc. (NASDAQ:TXG - Get Free Report) have been given a consensus recommendation of "Moderate Buy" by the seventeen ratings firms that are currently covering the stock, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation, seven have issued a hoNovember 11, 2024 | marketbeat.comARK Investment Management LLC Grows Stock Holdings in 10x Genomics, Inc. (NASDAQ:TXG)ARK Investment Management LLC boosted its holdings in 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 15.4% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 10,750,345 shares of the company's stock after buying an addNovember 8, 2024 | marketbeat.com10x Genomics to Present at the Wolfe Research 2024 Healthcare ConferenceNovember 7, 2024 | prnewswire.comEarnings Update: 10x Genomics, Inc. (NASDAQ:TXG) Just Reported And Analysts Are Trimming Their ForecastsNovember 2, 2024 | finance.yahoo.com10x Genomics price target lowered to $19 from $21 at BarclaysNovember 2, 2024 | markets.businessinsider.com10x Genomics (NASDAQ:TXG) Price Target Cut to $19.00 by Analysts at BarclaysBarclays cut their price objective on shares of 10x Genomics from $21.00 to $19.00 and set an "overweight" rating on the stock in a report on Friday.November 1, 2024 | marketbeat.comFY2024 EPS Estimates for 10x Genomics Boosted by Analyst10x Genomics, Inc. (NASDAQ:TXG - Free Report) - Stock analysts at Leerink Partnrs upped their FY2024 EPS estimates for 10x Genomics in a report released on Tuesday, October 29th. Leerink Partnrs analyst P. Souda now anticipates that the company will earn ($1.46) per share for the year, up from thNovember 1, 2024 | marketbeat.comAllspring Global Investments Holdings LLC Purchases 37,326 Shares of 10x Genomics, Inc. (NASDAQ:TXG)Allspring Global Investments Holdings LLC lifted its position in 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 2,280.1% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 38,963 shares of the company's stock after purchasinNovember 1, 2024 | marketbeat.com10x Genomics’ Visium HD selected by TechBio startup Cure51October 31, 2024 | msn.comAnalysts Offer Insights on Healthcare Companies: Atricure (ATRC), 10x Genomics (TXG) and Chugai Pharmaceutical Co (OtherCHGCF)October 31, 2024 | markets.businessinsider.com10X Genomics CEO Serge Saxonov Initiates Rule 10b5-1 Trading Plan Amid Strategic Financial ManeuveringOctober 31, 2024 | markets.businessinsider.comTechBio Startup Cure51 Selects 10x Genomics Visium HD for New Drug Discovery InitiativeOctober 31, 2024 | prnewswire.com10x Genomics, Inc.: 10x Genomics Reports Third Quarter 2024 Financial ResultsOctober 31, 2024 | finanznachrichten.deBuy Rating on 10x Genomics: Strategic Restructuring and Long-term Growth ProspectsOctober 31, 2024 | markets.businessinsider.comStifel Nicolaus Remains a Buy on 10x Genomics (TXG)October 31, 2024 | markets.businessinsider.comCitigroup Cuts 10x Genomics (NASDAQ:TXG) Price Target to $23.00Citigroup reduced their price target on shares of 10x Genomics from $35.00 to $23.00 and set a "buy" rating on the stock in a research report on Wednesday.October 30, 2024 | marketbeat.comThese Analysts Boost Their Forecasts On 10x Genomics After Q3 ResultsOctober 30, 2024 | benzinga.com10x Genomics Reports Mixed Q3 2024 ResultsOctober 30, 2024 | markets.businessinsider.com10x Genomics: Buy Rating Amid Short-term Disruptions and Long-term Growth ProspectsOctober 30, 2024 | markets.businessinsider.com10x Genomics (NASDAQ:TXG) Releases Quarterly Earnings Results, Beats Expectations By $0.04 EPS10x Genomics (NASDAQ:TXG - Get Free Report) issued its quarterly earnings results on Tuesday. The company reported ($0.30) EPS for the quarter, topping the consensus estimate of ($0.34) by $0.04. 10x Genomics had a negative net margin of 37.90% and a negative return on equity of 28.23%. The company had revenue of $151.65 million during the quarter, compared to analysts' expectations of $158.84 million. During the same quarter in the previous year, the company earned ($0.51) EPS. 10x Genomics's revenue was down 1.3% on a year-over-year basis.October 30, 2024 | marketbeat.com10x Genomics Inc (TXG) Q3 2024 Earnings Call Highlights: Navigating Challenges with Strategic ...October 30, 2024 | finance.yahoo.com10x Genomics: Balancing Market Challenges and Strategic OpportunitiesOctober 30, 2024 | markets.businessinsider.com10x Genomics Navigates Revenue Dip with New LaunchesOctober 30, 2024 | markets.businessinsider.com10x Genomics, Inc. 2024 Q3 - Results - Earnings Call PresentationOctober 29, 2024 | seekingalpha.com10x Genomics Reports Third Quarter 2024 Financial ResultsOctober 29, 2024 | prnewswire.com38,829 Shares in 10x Genomics, Inc. (NASDAQ:TXG) Purchased by Lecap Asset Management Ltd.Lecap Asset Management Ltd. acquired a new position in shares of 10x Genomics, Inc. (NASDAQ:TXG - Free Report) during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 38,829 shares of the company's stock, valued at approxOctober 24, 2024 | marketbeat.comPacBio includes Onso platform in 10x Genomics Compatible Partner ProgramOctober 23, 2024 | markets.businessinsider.com10x Genomics (TXG) Scheduled to Post Earnings on Tuesday10x Genomics (NASDAQ:TXG) will be releasing earnings after the market closes on Tuesday, October 29, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=634336)October 22, 2024 | marketbeat.com Get 10x Genomics News Delivered to You Automatically Sign up to receive the latest news and ratings for TXG and its competitors with MarketBeat's FREE daily newsletter. Email Address URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight. >> Register for the Workshop Now TXG Media Mentions By Week TXG Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TXG News Sentiment▼0.660.60▲Average Medical News Sentiment TXG News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TXG Articles This Week▼25▲TXG Articles Average Week Get 10x Genomics News Delivered to You Automatically Sign up to receive the latest news and ratings for TXG and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Cytek Biosciences News Standard BioTools News Pacific Biosciences of California News EyePoint Pharmaceuticals News Quanterix News Nautilus Biotechnology News Seer News Akoya Biosciences News Harvard Bioscience News Prenetics Global News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TXG) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 10x Genomics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share 10x Genomics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TXG Stock Alerts